Skip to main content
Back
Watch Compare

DarioHealth Corp.

Data quality: 83%
DRIO
Nasdaq Manufacturing Measuring & Analyzing Instruments
$7.25
▼ $0.09 (-1.23%)
Mkt Cap: 53.59 M
Price
$7.34
Mkt Cap
53.59 M
Day Range
—
52-Week Range
—
Volume
—
Open —
50D / 200D Avg
—
50D / 200D Avg
—

Quick Summary

Key Takeaways

Debt/Equity of 0.41 — conservative balance sheet
Negative free cash flow of -26.08 M

Growth

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Quality

Return on Equity
-60.05%
Below sector avg (-53.34%)
ROIC-27.98%
Net MarginN/A
Op. MarginN/A

Safety

Debt / Equity
0.41
Above sector avg (0.31)
Current Ratio4.55
Interest Coverage-12.14

Valuation

PE (TTM)
-1.28
Above sector avg (-1.47)
P/B Ratio0.72
EV/EBITDAN/A
Dividend YieldN/A

Price History

Financial Trends

Peer Comparison

vs Manufacturing sector median (1364 peers)
Metric Stock Sector Median
P/E -1.3 -1.5
P/B 0.7 1.6
ROE % -60.1 -53.3
Net Margin % — -41.5
Rev Growth 5Y % — 1.8
D/E 0.4 0.3

Analyst Price Target

5 analysts
Buy
Current
$7.25
+159.3%
Target
$18.80
$10.00
$20.00
$28.00
Forecast
Forward P/E -16.67
Forward EPS -$0.44
Est. Revenue 38.93 M

Earnings Estimates

Period EPS Est. Revenue Est. Analysts
FY2027 -$0.44
-$0.75 – -$0.12
 38.93 M 2
FY2026 -$2.07
-$2.42 – -$1.42
 26.36 M 3

Earnings Surprises

Last 4 quarters
Quarter Est. EPS Actual EPS Surprise
Q42025 -$1.59 -$0.77 +51.9%
Q32025 -$2.42 -$2.22 +8.1%
Q22025 -$2.07 -$4.09 -98.0%
Q12025 -$1.10 -$2.38 -116.0%

All Fundamental Metrics
Growth
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) N/A Net Income (TTM) -41.71 M
ROE -60.05% ROA -36.91%
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) -26.08 M
ROIC -27.98% FCF Growth (3Y) N/A
Safety
Debt / Equity 0.41 Current Ratio 4.55
Interest Coverage -12.14 Asset Turnover N/A
Working Capital 32.91 M Tangible Book Value 1.10 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -1.28 Forward P/E N/A
P/B Ratio 0.72 P/S Ratio N/A
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -48.68%
Market Cap 53.59 M Enterprise Value 52.30 M
Per Share
EPS (Diluted TTM) 10.12 Revenue / Share N/A
FCF / Share -3.57 OCF / Share -3.55
EPS CAGR (1Y) 1559.02% EPS CAGR (5Y) 25.57%
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion 62.53%
SBC-Adj. FCF N/A Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue — — — — —
Net Income -41.71 M -42.75 M -59.43 M -62.19 M -76.76 M
EPS (Diluted) 10.12 0.61 1.93 2.54 4.07
Gross Profit 12.67 M 13.27 M 5.98 M 9.66 M 3.96 M
Operating Income -36.66 M -57.74 M -56.19 M -56.81 M -76.49 M
EBITDA — — — — —
R&D Expenses 13.79 M 24.18 M 20.25 M 19.65 M 17.22 M
SG&A Expenses — — — — —
D&A — — — — —
Interest Expense 3.02 M — 1.88 M 1.88 M —
Income Tax 105,000.0 -1.85 M 64,000.0 4,000.0 32,000.0

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 110.08 M 118.88 M 96.39 M 119.19 M 100.77 M
Total Liabilities — — — — —
Shareholders' Equity 67.92 M 72.02 M 58.14 M 80.00 M 85.55 M
Total Debt 30.75 M 23.47 M 24.59 M 18.11 M —
Cash & Equivalents 21.80 M 27.76 M 36.80 M 49.36 M 35.81 M
Current Assets 35.07 M 40.53 M 47.33 M 65.52 M 45.61 M
Current Liabilities 9.32 M 16.64 M 12.49 M 19.35 M 14.38 M